US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 1.100
  • +0.080+7.84%
Close Aug 12 16:00 ET
  • 1.100
  • 0.0000.00%
Post 17:54 ET
229.04MMarket Cap-797P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.72%-26.88M
26.60%-48.66M
-0.54%-224.84M
11.41%-50.54M
11.80%-47.29M
-12.46%-60.71M
-12.42%-66.3M
4.13%-223.63M
-8.22%-57.05M
9.76%-53.62M
Net income from continuing operations
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
-95.96%-104.16M
-165.23%-114.51M
148.05%21.13M
-7.84%-192.28M
-38.61%-51.97M
-11.46%-53.16M
Depreciation and amortization
-58.38%2.57M
-54.74%2.53M
7.93%22.19M
-44.69%3.01M
43.22%7.42M
23.57%6.18M
13.02%5.58M
16.58%20.56M
11.96%5.44M
12.83%5.18M
Deferred tax
----
----
---6.34M
---140K
--182K
----
----
--0
--0
--0
Other non cash items
----
----
--1.12M
--0
----
----
----
----
----
----
Change In working capital
176.19%2.54M
94.40%-8.9M
-99.27%-164.03M
104.39%783K
79.29%-2.67M
85.99%-3.33M
-471.46%-158.81M
19.21%-82.32M
19.45%-17.85M
48.02%-12.91M
-Change in receivables
-96.94%126K
116.38%586K
66.51%3.15M
-25.96%425K
75.50%2.19M
310.17%4.11M
-283.80%-3.58M
1,934.95%1.89M
-74.20%574K
238.64%1.25M
-Change in prepaid assets
744.15%4.35M
-112.58%-783K
224.93%6.13M
3.73%974K
54.56%-389K
85.79%-675K
2,682.16%6.22M
31.58%-4.91M
232.63%939K
57.75%-856K
-Change in payables and accrued expense
-61.58%2.84M
28.62%-7.5M
-58.13%5.59M
176.80%10.81M
-120.64%-2.12M
267.07%7.4M
-391.05%-10.5M
274.16%13.35M
231.70%3.91M
786.62%10.27M
-Change in other current liabilities
-31.73%-1.59M
-0.84%-1.2M
-123.96%-5.06M
-251.53%-1.43M
-6.95%-1.23M
-9.55%-1.2M
-24.87%-1.19M
27.72%-2.26M
185.83%945K
-25.24%-1.15M
-Change in other working capital
----
----
-92.33%-173.85M
58.72%-9.99M
95.01%-1.12M
10.55%-12.97M
-411.60%-149.77M
-7.83%-90.39M
-23.48%-24.21M
-14.98%-22.41M
Cash from discontinued investing activities
Operating cash flow
55.72%-26.88M
26.60%-48.66M
-0.54%-224.84M
11.41%-50.54M
11.80%-47.29M
-12.46%-60.71M
-12.42%-66.3M
4.13%-223.63M
-8.22%-57.05M
9.76%-53.62M
Investing cash flow
Cash flow from continuing investing activities
-99.70%127K
0.31%35.84M
158.97%153.53M
-11.51%37.71M
379.51%37.63M
49.38%42.47M
1,995.48%35.73M
-76.11%59.29M
-19.04%42.61M
-122.08%-13.46M
Net PPE purchase and sale
--0
--0
-4.88%-21.16M
64.26%-2.67M
37.82%-2.74M
-1.74%-5.54M
-259.28%-10.2M
13.35%-20.17M
-161.51%-7.47M
15.25%-4.41M
Net business purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Net investment purchase and sale
--0
-21.96%35.84M
119.85%174.69M
-19.38%40.38M
546.14%40.37M
41.73%48.01M
910.74%45.93M
-70.74%79.46M
-9.74%50.09M
-113.67%-9.05M
Cash from discontinued investing activities
Investing cash flow
-99.70%127K
0.31%35.84M
158.97%153.53M
-11.51%37.71M
379.51%37.63M
49.38%42.47M
1,995.48%35.73M
-76.11%59.29M
-19.04%42.61M
-122.08%-13.46M
Financing cash flow
Cash flow from continuing financing activities
-108.18%-533K
176.46%22.12M
-82.77%14.59M
-99.15%167K
-100.23%-100K
-71.50%6.52M
610.66%8M
157.65%84.66M
824.95%19.54M
697.85%43.82M
Net common stock issuance
-110.01%-600K
147.22%22.52M
-82.20%15.11M
-104.02%-719K
-98.40%720K
-72.67%5.99M
--9.11M
213.18%84.87M
--17.91M
823.58%45.03M
Proceeds from stock option exercised by employees
----
----
-50.66%935K
-47.20%935K
33.49%-719K
----
----
-78.98%1.9M
-25.65%1.77M
-222.98%-1.08M
Net other financing activities
59.28%-79K
63.75%-402K
30.94%-1.45M
65.49%-49K
25.19%-101K
-4.30%-194K
32.42%-1.11M
35.42%-2.1M
47.41%-142K
48.67%-135K
Cash from discontinued financing activities
Financing cash flow
-108.18%-533K
176.46%22.12M
-82.77%14.59M
-99.15%167K
-100.23%-100K
-71.50%6.52M
610.66%8M
157.65%84.66M
824.95%19.54M
697.85%43.82M
Net cash flow
Beginning cash position
-30.61%55.33M
-54.19%46.7M
-43.48%101.94M
-39.61%58.01M
-42.68%68.33M
-34.51%79.74M
-43.48%101.94M
35.79%180.37M
-46.17%96.07M
-30.44%119.21M
Current changes in cash
-132.77%-27.29M
141.20%9.3M
28.81%-56.72M
-348.34%-12.66M
58.02%-9.77M
-337.14%-11.72M
61.64%-22.57M
-266.68%-79.68M
150.81%5.1M
-430.05%-23.26M
Effect of exchange rate changes
-182.11%-257K
-282.56%-670K
18.26%1.48M
74.58%1.35M
-533.07%-550K
140.77%313K
65.32%367K
576.81%1.25M
773.91%775K
353.57%127K
End cash Position
-59.34%27.79M
-30.61%55.33M
-54.19%46.7M
-54.19%46.7M
-39.61%58.01M
-42.68%68.33M
-34.51%79.74M
-43.48%101.94M
-43.48%101.94M
-46.17%96.07M
Free cash flow
59.42%-26.88M
36.39%-48.66M
-0.90%-246M
17.53%-53.21M
13.78%-50.04M
-11.48%-66.25M
-23.76%-76.5M
4.96%-243.8M
-16.11%-64.52M
10.21%-58.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.72%-26.88M26.60%-48.66M-0.54%-224.84M11.41%-50.54M11.80%-47.29M-12.46%-60.71M-12.42%-66.3M4.13%-223.63M-8.22%-57.05M9.76%-53.62M
Net income from continuing operations 68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M-95.96%-104.16M-165.23%-114.51M148.05%21.13M-7.84%-192.28M-38.61%-51.97M-11.46%-53.16M
Depreciation and amortization -58.38%2.57M-54.74%2.53M7.93%22.19M-44.69%3.01M43.22%7.42M23.57%6.18M13.02%5.58M16.58%20.56M11.96%5.44M12.83%5.18M
Deferred tax -----------6.34M---140K--182K----------0--0--0
Other non cash items ----------1.12M--0------------------------
Change In working capital 176.19%2.54M94.40%-8.9M-99.27%-164.03M104.39%783K79.29%-2.67M85.99%-3.33M-471.46%-158.81M19.21%-82.32M19.45%-17.85M48.02%-12.91M
-Change in receivables -96.94%126K116.38%586K66.51%3.15M-25.96%425K75.50%2.19M310.17%4.11M-283.80%-3.58M1,934.95%1.89M-74.20%574K238.64%1.25M
-Change in prepaid assets 744.15%4.35M-112.58%-783K224.93%6.13M3.73%974K54.56%-389K85.79%-675K2,682.16%6.22M31.58%-4.91M232.63%939K57.75%-856K
-Change in payables and accrued expense -61.58%2.84M28.62%-7.5M-58.13%5.59M176.80%10.81M-120.64%-2.12M267.07%7.4M-391.05%-10.5M274.16%13.35M231.70%3.91M786.62%10.27M
-Change in other current liabilities -31.73%-1.59M-0.84%-1.2M-123.96%-5.06M-251.53%-1.43M-6.95%-1.23M-9.55%-1.2M-24.87%-1.19M27.72%-2.26M185.83%945K-25.24%-1.15M
-Change in other working capital ---------92.33%-173.85M58.72%-9.99M95.01%-1.12M10.55%-12.97M-411.60%-149.77M-7.83%-90.39M-23.48%-24.21M-14.98%-22.41M
Cash from discontinued investing activities
Operating cash flow 55.72%-26.88M26.60%-48.66M-0.54%-224.84M11.41%-50.54M11.80%-47.29M-12.46%-60.71M-12.42%-66.3M4.13%-223.63M-8.22%-57.05M9.76%-53.62M
Investing cash flow
Cash flow from continuing investing activities -99.70%127K0.31%35.84M158.97%153.53M-11.51%37.71M379.51%37.63M49.38%42.47M1,995.48%35.73M-76.11%59.29M-19.04%42.61M-122.08%-13.46M
Net PPE purchase and sale --0--0-4.88%-21.16M64.26%-2.67M37.82%-2.74M-1.74%-5.54M-259.28%-10.2M13.35%-20.17M-161.51%-7.47M15.25%-4.41M
Net business purchase and sale ----------0------------------0--------
Net investment purchase and sale --0-21.96%35.84M119.85%174.69M-19.38%40.38M546.14%40.37M41.73%48.01M910.74%45.93M-70.74%79.46M-9.74%50.09M-113.67%-9.05M
Cash from discontinued investing activities
Investing cash flow -99.70%127K0.31%35.84M158.97%153.53M-11.51%37.71M379.51%37.63M49.38%42.47M1,995.48%35.73M-76.11%59.29M-19.04%42.61M-122.08%-13.46M
Financing cash flow
Cash flow from continuing financing activities -108.18%-533K176.46%22.12M-82.77%14.59M-99.15%167K-100.23%-100K-71.50%6.52M610.66%8M157.65%84.66M824.95%19.54M697.85%43.82M
Net common stock issuance -110.01%-600K147.22%22.52M-82.20%15.11M-104.02%-719K-98.40%720K-72.67%5.99M--9.11M213.18%84.87M--17.91M823.58%45.03M
Proceeds from stock option exercised by employees ---------50.66%935K-47.20%935K33.49%-719K---------78.98%1.9M-25.65%1.77M-222.98%-1.08M
Net other financing activities 59.28%-79K63.75%-402K30.94%-1.45M65.49%-49K25.19%-101K-4.30%-194K32.42%-1.11M35.42%-2.1M47.41%-142K48.67%-135K
Cash from discontinued financing activities
Financing cash flow -108.18%-533K176.46%22.12M-82.77%14.59M-99.15%167K-100.23%-100K-71.50%6.52M610.66%8M157.65%84.66M824.95%19.54M697.85%43.82M
Net cash flow
Beginning cash position -30.61%55.33M-54.19%46.7M-43.48%101.94M-39.61%58.01M-42.68%68.33M-34.51%79.74M-43.48%101.94M35.79%180.37M-46.17%96.07M-30.44%119.21M
Current changes in cash -132.77%-27.29M141.20%9.3M28.81%-56.72M-348.34%-12.66M58.02%-9.77M-337.14%-11.72M61.64%-22.57M-266.68%-79.68M150.81%5.1M-430.05%-23.26M
Effect of exchange rate changes -182.11%-257K-282.56%-670K18.26%1.48M74.58%1.35M-533.07%-550K140.77%313K65.32%367K576.81%1.25M773.91%775K353.57%127K
End cash Position -59.34%27.79M-30.61%55.33M-54.19%46.7M-54.19%46.7M-39.61%58.01M-42.68%68.33M-34.51%79.74M-43.48%101.94M-43.48%101.94M-46.17%96.07M
Free cash flow 59.42%-26.88M36.39%-48.66M-0.90%-246M17.53%-53.21M13.78%-50.04M-11.48%-66.25M-23.76%-76.5M4.96%-243.8M-16.11%-64.52M10.21%-58.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday-0.87%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.16%